Listed

TherapeuticsMD, Inc.: Form 10-K for the period ended Dec 31, 2013

Filed with the SEC on Mar 5, 2014 and accepted by EDGAR at Mar 5, 2014, 17:10 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-10-01 to 2013-12-31$2.9mus-gaap:SalesRevenueNet
Revenue12 months2013-01-01 to 2013-12-31$8.8mus-gaap:SalesRevenueNet
Cost of revenue12 months2013-01-01 to 2013-12-31$2.0mus-gaap:CostOfGoodsSold
Gross profit3 months2013-10-01 to 2013-12-31$2.4mus-gaap:GrossProfit
Gross profit12 months2013-01-01 to 2013-12-31$6.8mus-gaap:GrossProfit
Research and development12 months2013-01-01 to 2013-12-31$13.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2013-01-01 to 2013-12-31$19.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2013-01-01 to 2013-12-31−$25.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2013-01-01 to 2013-12-31$1.2mus-gaap:InterestExpense
Net income3 months2013-10-01 to 2013-12-31−$8.4mus-gaap:NetIncomeLoss
Net income12 months2013-01-01 to 2013-12-31−$28.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-10-01 to 2013-12-31−$0.06us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2013-01-01 to 2013-12-31−$0.22us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2013-01-01 to 2013-12-31−$20.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2013-01-01 to 2013-12-31$40.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-12-31$54.2mus-gaap:Cash
Current assetsAt period end2013-12-31$59.4mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$62.0mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$7.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$7.3mus-gaap:Liabilities
Shareholders' equityAt period end2013-12-31$54.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001387131-14-000771. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.